Marshall Islands vs Palau: Prevalence rate of diabetes in adults
Marshall Islands
21.1
in 2014
Palau
23.2
in 2014
Marshall Islands rank
10th
Palau rank
7th
Prevalence rate of diabetes in adults over time
- Marshall Islands
- Palau
How they compare
Palau currently reports 23.2 against 21.1 in Marshall Islands, a difference of 2.1.
That makes Palau's figure about 1.1 times Marshall Islands's.
Across all 35 years both countries report, Palau has been ahead every year.
Marshall Islands ranks 10th and Palau ranks 7th of 190 countries.
Palau has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Marshall Islands | Palau | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 11.62 | 14.25 | 2.63 | Palau |
| 1990s | 15.97 | 18.37 | 2.4 | Palau |
| 2000s | 19.18 | 21.29 | 2.11 | Palau |
| 2010s | 20.72 | 22.86 | 2.14 | Palau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Marshall Islands or Palau?
- Palau, at 23.2 against 21.1 in Marshall Islands as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Marshall Islands and Palau?
- 2.1, with Palau ahead.
- How many years of comparable data are there for Marshall Islands and Palau?
- 35 years are reported by both, from 1980 to 2014.
- How do Marshall Islands and Palau rank globally for prevalence rate of diabetes in adults?
- Marshall Islands ranks 10th and Palau ranks 7th of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.